Haifeng Zhu

4PUBLICATIONS
45CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Suyu Liu, Kangyu Lin

|May 06, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Nicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes

|Aug 01, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail

|Mar 11, 2023
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth.

Haijie Xiao, Haifeng Zhu, Oliver Bögler

Pageof 1